✦ LIBER ✦
71-P: A longitudinal analysis of transplant recipients treated with rituximab (anti-CD20): B cell ablation is not effective in depleting pre-existing anti-HLA class I or class II antibodies
✍ Scribed by Allison Gasiewski; Erin Pierce; Jane Kearns; Eline Luning Prak; Simin Goral; Alden Doyle; Roy Bloom; James F. Markmann; Barry Miller; Mariell Jessup; Lee Goldberg; Ali Naji; Donald Tsai; Malek Kamoun
- Book ID
- 116531277
- Publisher
- Elsevier Science
- Year
- 2006
- Tongue
- English
- Weight
- 49 KB
- Volume
- 67
- Category
- Article
- ISSN
- 0198-8859
No coin nor oath required. For personal study only.